Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-117,496
Closed -$8.88M 797
2026
Q1
$8.88M Buy
117,496
+11,616
+11% +$873K 0.04% 350
2025
Q4
$7.89M Sell
105,880
-6,515
-6% -$476K 0.04% 386
2025
Q3
$7.58M Sell
112,395
-7,770
-6% -$516K 0.04% 402
2025
Q2
$7.83M Buy
120,165
+34,046
+40% +$2.04M 0.04% 391
2025
Q1
$5.31M Buy
86,119
+1,709
+2% +$113K 0.03% 445
2024
Q4
$6.09M Buy
84,410
+10,703
+15% +$836K 0.04% 414
2024
Q3
$6M Sell
73,707
-1,554
-2% -$124K 0.03% 427
2024
Q2
$5.59M Sell
75,261
-6,039
-7% -$453K 0.03% 424
2024
Q1
$6.34M Buy
+81,300
New +$6.05M 0.04% 418

Other funds holding HOLX

Resona Asset Management's HOLX Position: Q2 2026 in Review

Resona Asset Management sold out of Hologic (HOLX) in Q2 2026, closing a stake of 117,496 shares — an estimated $8.88M sold.

Resona Asset Management first reported a position in HOLX in Q1 2024 and held it in 9 quarters. The position peaked at $8.88M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Resona Asset Management reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Resona Asset Management sold 117,496 Hologic shares in Q2 2026, an estimated $8.88M.
  • Resona Asset Management first reported a position in Hologic in Q1 2024 and held it in 9 quarters.
  • Resona Asset Management's Hologic position peaked at $8.88M in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Resona Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.